… of this 2-part consensus, the Taiwan … , chronic kidney disease, decompensated cirrhosis,
HCC, liver and other solid organ transplantations, receiving an HCV viremic organ, hepatitis B …

… , which were approved by the Food and Drug Administration (FDA) in 2011. The … Taiwanese
patients, with an SVR rate of 66.7% in both treatment-experienced HCV GT1 and hepatitis B …

… for CHB treatment in the latest guidelines and consensus statements were discussed. The
… recruited in the REVEAL-HBV study by Taiwan investigators had normal ALT levels, and a …

… Hepatitis Control Committee, the Taiwanese government approved a nationwide reimbursement
program for these two regimens for chronic hepatitis B … of chronic hepatitis B in Taiwan. …

… TORCH-B is a multicentre, double-blind, placebo-controlled, parallel-group, randomised
trial done at six teaching hospitals in Taiwan that enrolled patients with chronic hepatitis B. …

… consensus guideline suggested that high-risk patients (ie, those with chronic hepatitis B and
… All consensus statements were contributed by two expert groups and the following experts (…

… Hepatitis B virus (HBV) infection … were chronic hepatitis B surface antigen (HBsAg) carriers,
with highest endemicity in African and Western Pacific regions [Citation1,Citation2]. Chronic …

… Recently, two independent cohort studies from Taiwan showed the comparable cumulative
incidence of HCC between cirrhotic patients in NA discontinued arm and in those with …

… of hepatitis The prevalence of coexisting MAFLD and chronic hepatitis B (CHB) or chronic
hepatitis C … An inverse association has been reported between hepatitis B virus replication and …

… and formulate a consensus statement on HCV screening and management among … guidelines
as well as from real-world clinical experiences, the Taiwan experts reached a consensus …